… Clinical effect and safety meta-analysis of adjuvant chemotherapy of ginseng 1 capsule
for nonsmall cell lung cancer. Yunnan J Tradit Chin Med Mater Med (Chin) 2015;7:14–16. …

… The geostatistical analysis of health data is illustrated with an example for lung cancer, which
has been the leading cause of cancer deaths in the United States for several decades. Figs…

… As we know, recent advancement in the therapy for lung cancer is mainly the discovery of
targetable mutations and histology-based therapeutic regimen selection. Histological tumor …

… Lung cancer is the leading cause of cancerrelated mortality worldwide, accounting for 26%–29%
of all cancer deaths.(1) Approximately 85% of lung cancer is non-small cell lung cancer …

… combining bronchial artery infusion in lung cancer of the old［J］.… of RFA with GP on advanced
stage lung cancer［J］.Chin J … for therapy of RFA on advanced stage lung cancer［J］.Chin J …

… for stage III A non-small cell lung cancer (NSCLC) before surgical operation. … -small cell
lung cancer. Acta Acad Med Qingdao Univ (Chin) 2007;43:91–94. … non-small cell lung cancer …

… the cancer itself or by cancer treatment. It occurs in half of newly diagnosed cancer patients
… (3) Up to 67% of patients with lung cancer receiving chemotherapy have experienced loss …

… small cell lung cancer who visited our hospital were enrolled in the study and randomly and
… because she had intracranial metastasis and stopped lung radiation. There was no patient …

… ) combined with docetaxel (DTX) on lung cancer was evaluated. The results showed … lung
cancer. This study provides new ideas for the development of highly effective anti-lung cancer …

… no reports on the induction of cancer cell death by BXD or its … treatment of A549 human lung
cancer cells with cisplatin or … of lung cancer (especially non-smallcell lung cancer, NSCLC)…